Bloomberg -
19 January 2018, 18:58 (+ 2311 days 11 hours and 1 minutes) Economics
Shares of generic-drug makers including Mylan NV and Teva Pharmaceutical Industries Ltd. fell after the Justice Department's antitrust division said it might sue them for damages in a price-fixing probe.